These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 15128623)

  • 1. Will we ever know if leukoreduction of red blood cells should be performed?
    Carson JL; Berlin JA
    Can J Anaesth; 2004 May; 51(5):407-10. PubMed ID: 15128623
    [No Abstract]   [Full Text] [Related]  

  • 2. Transfusion of leukoreduced red blood cells may decrease postoperative infections: two meta-analyses of randomized controlled trials.
    Fergusson D; Khanna MP; Tinmouth A; Hébert PC
    Can J Anaesth; 2004 May; 51(5):417-24. PubMed ID: 15128625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a universal leukoreduction program in Canada.
    Hébert PC; Fergusson DA;
    Vox Sang; 2002 Aug; 83 Suppl 1():207-9. PubMed ID: 12617139
    [No Abstract]   [Full Text] [Related]  

  • 4. Transfusion: is merely not bad good enough?
    Engoren M
    Acta Anaesthesiol Scand; 2011 Sep; 55(8):907-9. PubMed ID: 22092164
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mechanisms of immunomodulation after transfusion of allogeneic and autologous red cell concentrate].
    Innerhofer P; Kühbacher G
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Nov; 37(11):681-4. PubMed ID: 12404147
    [No Abstract]   [Full Text] [Related]  

  • 6. Risks associated with the transfusion of various blood products in aortic valve replacement.
    Bjursten H; Al-Rashidi F; Dardashti A; Brondén B; Algotsson L; Ederoth P
    Ann Thorac Surg; 2013 Aug; 96(2):494-9. PubMed ID: 23816419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukoreduction vs buffy-coat depletion and the safety of blood transfusion.
    Wallis JP
    JAMA; 2003 Sep; 290(12):1580; author reply 1580. PubMed ID: 14506115
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions.
    Hébert PC; Fergusson D; Blajchman MA; Wells GA; Kmetic A; Coyle D; Heddle N; Germain M; Goldman M; Toye B; Schweitzer I; vanWalraven C; Devine D; Sher GD;
    JAMA; 2003 Apr; 289(15):1941-9. PubMed ID: 12697796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes following institution of universal leukoreduction of blood transfusions for premature infants.
    Fergusson D; Hébert PC; Lee SK; Walker CR; Barrington KJ; Joseph L; Blajchman MA; Shapiro S
    JAMA; 2003 Apr; 289(15):1950-6. PubMed ID: 12697797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukoreduction program for red blood cell transfusions in coronary surgery: association with reduced acute kidney injury and in-hospital mortality.
    Romano G; Mastroianni C; Bancone C; Della Corte A; Galdieri N; Nappi G; De Santo LS
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):188-95. PubMed ID: 20416894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Canadian Universal Leukoreduction Program.
    Blackall DP
    Curr Hematol Rep; 2003 Nov; 2(6):493-4. PubMed ID: 14561393
    [No Abstract]   [Full Text] [Related]  

  • 12. Limited efficacy of universal leucodepletion in reducing the incidence of febrile non-haemolytic reactions in red cell transfusion.
    Ibojie J; Greiss M; Urbaniak SJ
    Transfus Med; 2002 Dec; 12(6):387-9. PubMed ID: 12473158
    [No Abstract]   [Full Text] [Related]  

  • 13. Concepts of blood transfusion in adults.
    Goodnough LT; Levy JH; Murphy MF
    Lancet; 2013 May; 381(9880):1845-54. PubMed ID: 23706801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 and C-reactive protein load in pre-storage and post-storage white blood cell-filtered red blood cell transfusions in premature infants.
    Say B; Sari FN; Oguz SS; Degirmencioglu H; Arayici S; Kadioglu Simsek G; Ibrisim EG; Dilmen U
    Transfus Med; 2015 Jun; 25(3):170-3. PubMed ID: 25991421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Packed red blood cell transfusions in critically ill patients.
    Collins TA
    Crit Care Nurse; 2011 Feb; 31(1):25-33; quiz 34. PubMed ID: 21285463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpretation of atypical patterns encountered when using a flow cytometry-based method to detect residual leukocytes in leukoreduced red blood cell components.
    Janatpour K; Paglieroni TG; Schuller L; Foley K; Rizzardo T; Holland PV
    Cytometry; 2002 Oct; 50(5):254-60. PubMed ID: 12360575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact on early and late mortality after blood transfusion in coronary artery bypass graft surgery.
    Santos AA; Sousa AG; Thomé HO; Machado RL; Piotto RF
    Rev Bras Cir Cardiovasc; 2013 Mar; 28(1):1-9. PubMed ID: 23739927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact on early and late mortality after blood transfusion in CABG surgery.
    Giffhorn H
    Rev Bras Cir Cardiovasc; 2013 Mar; 28(1):150-1. PubMed ID: 23739944
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical effects of different types of red cell concentrates in patients with thalassemia and sickle cell disease.
    Cabibbo S; Fidone C; Antolino A; Manenti OG; Garozzo G; Travali S; Bennardello F; Di Stefano R; Bonomo P
    Transfus Clin Biol; 2007 Dec; 14(6):542-50. PubMed ID: 18434227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood transfusion and monitoring. Immediate transfusion reactions. Erythrocyte transfusion].
    Riche H
    Soins; 1996 Apr; (605):23-6. PubMed ID: 8716245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.